|

Tau PET scan using MK-6240 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: tau PET

Pipeline

Phase 3: 1

Top Sponsors

  • University of California, Irvine1

Indications

  • Alzheimer's Disease1
  • Cognitive Decline1
  • Cognitive Impairment1
  • Alzheimer Disease1

Irvine, California1 trial

Biomarker Exploration in Aging, Cognition and Neurodegeneration

University of California, Irvine

Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.